Merck & Co. Inc.

AI Score

0

Unlock

87.13
-0.15 (-0.17%)
At close: Feb 10, 2025, 10:31 AM
undefined%
Bid 87.11
Market Cap 220.39B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 6.74
PE Ratio (ttm) 12.93
Forward PE n/a
Analyst Buy
Ask 87.14
Volume 2,938,704
Avg. Volume (20D) 12,877,548
Open 87.20
Previous Close 87.28
Day's Range 86.96 - 88.60
52-Week Range 86.96 - 134.63
Beta undefined

About MRK

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops...

Sector Healthcare
IPO Date Jan 13, 1978
Employees 70,000
Stock Exchange NYSE
Ticker Symbol MRK

Analyst Forecast

According to 14 analyst ratings, the average rating for MRK stock is "Buy." The 12-month stock price forecast is $115, which is an increase of 31.99% from the latest price.

Buy 57.14%
Hold 28.57%
Sell 7.14%
Stock Forecasts

Next Earnings Release

Merck & Co. Inc. is scheduled to release its earnings on Apr 24, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
-9.07%
Merck shares are trading lower after the company i... Unlock content with Pro Subscription
2 weeks ago
+2.5%
Merck shares are trading higher after the company announced WELIREG has gained FDA priority review.